Triple
T13959264
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Gamaleya Research Institute |
E335748
|
entity |
| Predicate | developed |
P73
|
FINISHED |
| Object | Sputnik M COVID-19 vaccine |
E1071419
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Sputnik M COVID-19 vaccine | Statement: [Gamaleya Research Institute, developed, Sputnik M COVID-19 vaccine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sputnik M COVID-19 vaccine Context triple: [Gamaleya Research Institute, developed, Sputnik M COVID-19 vaccine]
-
A.
Sputnik V COVID-19 vaccine
chosen
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
B.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
C.
CoronaVac
CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
-
D.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
E.
mRNA-1273
mRNA-1273 is a messenger RNA–based COVID-19 vaccine that instructs cells to produce the SARS-CoV-2 spike protein to elicit an immune response.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c61f3508190aaf2ca0dc0002c59 |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e7b2f908190aa32f22298964746 |
completed | April 14, 2026, 12:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fbc321c600819085052392de9b0b53 |
completed | May 6, 2026, 10:39 p.m. |
Created at: April 9, 2026, 10:17 p.m.